Abvance Featured in Startup Health

Abvance’s Novel Coformulation of Insulin and Glucagon Could Revolutionize Diabetes Care A team of scientists and physicians have discovered that insulin and glucagon, long thought solely to counteract one another as they lower or raise blood sugar levels, respectively, could actually work together for better and safer glycemic control. If Abvance’s foundational work proves out, people with diabetes who require [...]

September 28th, 2023|
Go to Top